Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening

Journal of the American College of Cardiology

Volumn 29, Issue 6, 1997, Pages 1371-1379

  Van Belle, Eric ^a   Tio, Fermin O ^b   Chen, Donghui ^a   Maillard, Luc ^a   Chen, Dongfen ^a   Kearney, Marianne ^a   Isner, Jeffrey M ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; GENE TRANSFER; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; STENT; THROMBOGENESIS;

ANGIOPLASTY, BALLOON; ANIMALS; DNA, COMPLEMENTARY; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE TRANSFER TECHNIQUES; ILIAC ARTERY; LYMPHOKINES; RABBITS; STENTS; THROMBOSIS; TUNICA INTIMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030983590     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00049-1     Document Type: Article

References (46)

1. Serruys PW, DeJaegere P, Kiemeneij F, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty with coronary artery disease. N Engl J Med. 331:1994;489-495.
2. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
3. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 91:1995;1676-1688.
4. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmatz-Schatz stents in human coronary arteries early outcome of the Benestent-II Pilot study . Circulation. 93:1996;414-422.
5. Hehrlein C, Stintz M, Kinscherf R, et al. Pure beta-particle-emitting stents inhibit neointima formation in rabbits. Circulation. 93:1996;641-645.
6. Laird JR, Carter AJ, Kufs WA, et al. Inhibition of neointimal proliferation with low-dose irradiation from a beta-particle-emitting stent. Circulation. 93:1996;529-536.
7. Waksman R, Robinson KA, Crocker IR, et al. Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries. Circulation. 92:1995;1383-1386.
8. Folts JD, Maalej N, Keaney JF Jr., Loscalzo J. Palmaz-Schatz stents coated with a NO donor reduces reocclusion when placed in pig carotid arteries for 28 days [abstract]. J Am Coll Cardiol. 27:(Suppl A):1996;86A.
9. Clowes AW. Improving the interface between biomaterials and the blood The gene therapy approach . Circulation. 93:1996;1319-1320.
10. Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation. 80:1989;1347-1353.
11. Flugelman MY, Virmani R, Leon MB, Bowman RL, Dichek DA. Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. Circ Res. 70:1992;348-354.
12. Dunn PF, Kurt ND, Jones M, et al. Seeding of vascular grafts with genetically modified endothelial cells Secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo . Circulation. 93:1996;1439-1446.
13. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
14. Lindner V, Majack RA, Reidy MA. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest. 85:1990;2004-2008.
15. Bjornsson TD, Dryjski M, Tluczek J, et al. Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci USA. 88:1991;8651-8655.
16. Asahara T, Bauters C, Pastore CJ, et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 91:1995;2793-2801.
17. Scott NA, Candal FJ, Robinson KA, Ades EW. Seeding of intracoronary stents with immortalized human microvascular endothelial cells. Am Heart J. 129:1995;860-866.
18. Tischer E, Mitchell R, Hartmann T, et al. The human gene for vascular endothelial growth factor multiple protein forms are encoded through alternative exon splicing . J Biol Chem. 266:1991;11947-11954.
19. Losordo DW, Pickering JG, Takeshita S, et al. Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression . Circulation. 89:1994;785-792.
20. Takeshita S, Losordo DW, Kearney M, Isner JM. Time course of recombinant protein secretion following liposome-mediated gene transfer in a rabbit arterial organ culture model. Lab Invest. 71:1994;387-391.
21. Van Belle E, Vallet B, Auffray JL, et al. NO synthesis is involved in the structural and functional effects of ACE inhibitors in injured arteries. Am J Physiol. 270:1996;H298-H305.
22. Mancini CBJ, Simon SB, McGillem MJ, LeFree MT, Friedman HZ, Vogel RA. Automated quantitative arteriography morphologic and physiologic validation in vivo of a rapid digital angiographic method . Circulation. 75:1987;452-460.
23. Isner JM, Walsh K, Rosenfield K, et al. Arterial gene therapy for restenosis. Human Gene Ther. 7:1996;989-1011.
24. Bonnerot C, Rocancourt D, Briand P, Grimber G. A beta-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc Natl Acad Sci USA. 84:1987;6795-6799.
25. Riessen R, Isner JM. Prospects for site-specific delivery of pharmacologic and molecular therapies. J Am Coll Cardiol. 23:1994;1234-1244.
26. Takeshita S, Tsurumi Y, Couffinhal T, et al. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest. 75:1996;487-502.
27. Bray DF, Bagu J, Koegler P. Comparison of hexamethyldisilazane (HMDS), Peldri II, and critical point drying methods for scanning electron microscopy and biological specimens. Microvasc Res. 26:1993;489-495.
28. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury results in a porcine model . J Am Coll Cardiol. 19:1992;267-274.
29. Weidinger FF, McLenachan JM, Cybulsky MI, et al. Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation. 81:1990;1667-1679.
30. Shimokawa H, Flavahan NA, Vanhoutte PM. Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Circ Res. 65:1989;740-753.
31. Luscher TF, Tshuci MR. Endothelial dysfunction in coronary artery disease. Annu Rev Med. 44:1993;395-418.
32. Benzuly KH, Glazier S, Grines CL, O'Neill WW, Safian RD. Coronary perforation an unreported complication after intracoronary stent implantation [abstract] . J Am Coll Cardiol. 27:(Suppl A):1996;252A.
33. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury I. Smooth muscle growth in the absence of endothelium . Lab Invest. 49:1983;327-333.
34. Merrilees MJ, Scott LJ. Effects of endothelial removal and regeneration on smooth muscle glycosaminoglycan synthesis and growth in rat carotid artery in organ culture. Lab Invest. 52:1985;409-419.
35. Dussaillant GR, Mintz GS, Pichard AD, et al. Small stent size and intimal hyperplasia contribute to restenosis a volumetric intravascular ultrasound analysis . J Am Coll Cardiol. 26:1995;720-724.
36. Carter AJ, Laird JR, Farb A, Kufs W, Wortham DC, Virmani R. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferation restonis model. J Am Coll Cardiol. 24:1994;1398-1405.
37. Karas SP, Gravanis MB, Santoian EC, Robinson KA, Anderbert KA, King SB III. Coronary intimal proliferation after balloon injury and stenting in swine an animal model of restenosis . J Am Coll Cardiol. 20:1992;467-474.
38. Hehrlein C, Gollan C, Donges BS, et al. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation. 92:1995;1570-1575.
39. Kearney M, Pieczek A, Haley L, Schainfeld R, Rosenfield K, Isner JM. Histopathology stent restenosis [abstract]. Circulation. 94:(Suppl I):1996;I-620.
40. Guzman RJ, Hirschowitz EA, Brody SL, Crystal RG, Epstein SE, Finkel T. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA. 91:1994;10732-10736.
41. von der Leyen HE, Leyen VD, Gibbons GH, et al. Gene therapy inhibiting neointimal vascular lesion in vivo transfer of endothelial cellnitric oxide synthase gene . Proc Natl Acad Sci USA. 92:1995;1137-1141.
42. Chang MW, Barr E, Jonathan S, et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 267:1995;518-522.
43. Ohno T, Gordon D, San H, et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 265:1994;781-784.
44. Chang MW, Barr E, Lu MM, Barton K, Leiden JM. Adenovirus-mediated overexpression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest. 96:1995;2260-2268.
45. Hardhammar PA, vanBeukesom HMM, Emmanuelsson HU, et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation. 93:1996;423-430.
46. Fischell TA, Kharman BK, Fishcell DR, et al. Low-dose, beta-particle emission from "stent" wire results in complete, localized inhibition of smooth muscle proliferation. Circulation. 90:1994;2956-2963.